September 2011 Issue of MMM
As everybody always tells me, good talent is always in demand - especially now, and especially in this industry.
Mark Bard gave the healthcare industry a shared vocabulary with which to talk about digital health in Manhattan Research. Now he's working on giving the ...
Despite the job cuts that have darkened the pharma job market, top talent will always be in demand—and most respondents to MM&M's 25th Career & ...
Adaptation is second nature to agencies. But how do leaders help staff transition to digital, or soothe anxiety after a merger? As Tanya Lewis finds, ...
Leaders never follow, goes the adage. But on your way to the top, it couldn't hurt to emulate these biopharmaceutical executives, whose career steps got ...
An esteemed panel of 40 healthcare executives scored hundreds of Awards entries. The result is the shortlist of finalists from which the winners will be ...
A new kind of "soft" researcher may be in increasing demand: a "CreaSearcher," someone who combines creative and qualitative research, bridging what has traditionally been ...
This time, the media is being very positive. News reports about the new treatment for chronic lymphocytic leukemia are ripe with palpable excitement.
The FDA is moving cautiously on a call by the Institute of Medicine (IOM) to scrap the approvals process for many medical devices.
To ease the plight of limited face time that sales reps are granted by physicians, AbelsonTaylor (AT) has created an interactive detailing platform for the ...
In an effort to further slim its budgetary waistline, Merck, though having reported a 7% raise in sales during Q2, has announced plans to cut ...
Featuring news about Manhattan Research, Kaon Interactive and InfoMedics
Med Ed Report
Eli Lilly debuted an expanded doctor-payment report, adding food, travel and other non-cash gifts given to doctors and healthcare groups.
In a sign of industry's ongoing desire to broaden its CME funding outlook, a couple of programs recently supported by Pfizer aim to foster practice-based ...
The number of papers found tainted after appearing in peer-reviewed journals soared between 2001 and 2010, The Wall Street Journal reports.
Featuring news about the Centers for Disease Control, Cegedim, CBI, KnowledgePoint 360 and SmithBucklin
Now in its 19th printed edition, The Merck Manual, published as a not-for profit service by the global pharma company of the same name, has ...
Lippincott Williams & Wilkins (LWW) has announced gains in impact factor (IF)—which quantifies the relative influence of a scholarly journal in its scientific field—with 23 ...
Featuring news about Dove Medical Press, Elsevier and BMJ Group
Wolters Kluwer Health is divesting its Pharma Solutions unit to focus on apps and journals. Does this move away from an audience of pharmas and ...
Like all drug firms with a Facebook presence, Pfizer lost some control in August when Facebook opened up pharma company pages to public commenting. But ...
WebMD is expanding its wellness and prevention offering with several children's fitness sites aimed at besting childhood obesity.
Featuring news about Purdue, Augme Technologies and iHadCancer.com
Kim Kardashian revealed she has psoriasis in July when her diagnosis with the disease featured in an episode of her show, "Keeping Up With The ...
For some reason, pharmaceutical professional advertising encourages the overuse of visual puns. How many times have you seen a large animal used to convey "strength" ...
European Union regulators are weighing relaxing a prohibition on direct communication with patients by drug companies.
EMD Serono refreshed its "Birds & Bees" fertility issues awareness campaign with a Facebook page and a music video.
Desperate Housewives star Dana Delany will serve as the face of Pfizer's "Women Move the World" campaign for the OTC calcium and vitamin D supplement ...
Featuring news on Sanofi and Chattem, LifeScan, and Macmillan Cancer Support
Assertions that challenge the American Medical Association's commitment to its data-mining alternative are "unfounded speculation that ignores the facts," said AMA president Dr. Peter Carmel.
Wolters Kluwer said it will divest its Pharma Solutions business unit, in two parts.
Wishbone founder Steve Michaelson and chief strategy officer Judy Capano retired last month as the shop was absorbed into Rosetta, which acquired the agency a ...
Omnicom's DDB Worldwide snapped up London and Philly-based medical communications and PR firm Synergy.
Featuring news about Siren Interactive, Dudnyk, Centron, Ogilvy Washington and Flaum Partners
Social media for regulated industry is a green field of opportunity. But to maximize the opportunity, we must accommodate the reality of a messier world. ...
THE NME approvals at FDA this year already equal the total approved for all of last year— 21 as of July 31—leading some FDA watchers ...
FDA's top enforcer has warned that cuts to the agency's budget now being contemplated by some in Congress could result in as many as 2,000 ...
If you listen to senior leadership from pharma firms or associated service providers, "good people" are always mentioned as a key concern and critical need.
Agencies that take a broad-spectrum approach to healthcare marketing, i.e., develop expertise in multiple sectors rather than focusing their resources on just one area, can ...
A lot of ink has been spilt on the decline of the blockbuster and the search for a new specialty-product commercial model. But less attention ...
- McCann Health forms new global consultancy
- Alexion uses superheroes, social media to raise rare-disease awareness
- Five things for pharma marketers to know: Tuesday, September 20, 2016
- Five things for pharma marketers to know: Wednesday, September 21, 2016
- Five things for pharma marketers to know: Monday, September 19, 2016
- Merck educates doctors about biosimilars, long before it will sell one in the U.S.
- 4 trends with the potential to change behavior in the patient journey
- When it comes to professional ads, print makes its comeback
- 2016 Pharma Report: All the data in one place
- What do physicians think about biosimilars?
- The FDA denies approval of abuse-deterrent opioid after promotional warning
- Five things for pharma marketers to know: Monday, September 26, 2016
- The FDA, Astellas, and Accenture use innovation competitions to help address business challenges
- The FDA approves Amgen's biosimilar version of Humira
- Five things for pharma marketers to know: Friday, September 23, 2016